ResearcherUniversity of FloridaActive in the last 2 years
Z. Hugh Fan
Matched on ORCID iD 0000-0002-1812-8016; OpenAlex author ID A5020886212, A5139704435. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 7
- Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial. Co-author DOI 10.1093/oncolo/oyag250↗
- Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/bios12040206↗
- Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1002/onco.13853↗
- Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.7150/thno.28745↗
- A Novel Microfluidic Device for Isolation of Circulating Tumor Cells from Pancreatic Cancer Blood Samples. Last author DOI 10.1007/978-1-4939-7144-2_3↗
- "Tissue is the issue": circulating tumor cells in pancreatic cancer. Co-author DOI 10.1007/s12029-014-9638-3↗
- Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Last author DOI 10.1039/c3lc51017d↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Thomas J. George · 7 shared papers, 2014–2026 · strength 0.82
- Paper Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI… DOI 10.1093/oncolo/oyag250↗
- Paper Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.3390/bios12040206↗
- Paper Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcin… DOI 10.1002/onco.13853↗
- Steven J. Hughes · 2 shared papers, 2021–2026 · strength 0.35
- Paper Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI… DOI 10.1093/oncolo/oyag250↗
- Paper Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcin… DOI 10.1002/onco.13853↗
- Sherise Chantell Rogers · 1 shared paper, 2026 · strength 0.24
- Ryan Michael Thomas · 1 shared paper, 2026 · strength 0.24
- Omar Roger Kayaleh · 1 shared paper, 2026 · strength 0.24
- Ibrahim Nassour · 1 shared paper, 2026 · strength 0.24
- Kathryn E. Hitchcock · 1 shared paper, 2026 · strength 0.24
- Jesus C. Fabregas · 1 shared paper, 2026 · strength 0.24
- Chen Liu · 3 shared papers, 2014–2019 · strength 0.21
- Paper Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adeno… DOI 10.7150/thno.28745↗
- Paper "Tissue is the issue": circulating tumor cells in pancreatic cancer. DOI 10.1007/s12029-014-9638-3↗
- Paper Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. DOI 10.1039/c3lc51017d↗
- Jose I. Varillas · 2 shared papers, 2017–2019 · strength 0.20
- Pablo Dopico · 1 shared paper, 2022 · strength 0.16
- Andrew R. Judge · 1 shared paper, 2021 · strength 0.12
- Miles E. Cameron · 1 shared paper, 2021 · strength 0.12
- Jose Gilberto Trevino · 1 shared paper, 2021 · strength 0.12
- Weian Sheng · 2 shared papers, 2014 · strength 0.10
- Olorunseun Olatunji Ogunwobi · 2 shared papers, 2014 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.